Invokana 300 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FCL0R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,069
Award facts
- Contract value 100% obligated
- $15,068.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Invokana 300 mg tablets (90-count units) valued at $15,068.54 under a firm fixed-price contract. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability to supply a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Invokana, a diabetes medication, exemplifies the company's role in supporting military and veteran healthcare supply needs through the DLA's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DR26FCL0R?
SPE2DR26FCL0R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FCL0R worth?
The government has obligated $15,069 on SPE2DR26FCL0R.
Is contract SPE2DR26FCL0R an order under another contract?
Yes. SPE2DR26FCL0R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCL0R competed?
The extent of competition for SPE2DR26FCL0R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award